SF164

Public postsecondary institutions maintenance of a supply of opiate antagonists on system campuses requirement
Legislative Session 94 (2025-2026)

Related bill: HF862

AI Generated Summary

Purpose

To require public postsecondary institutions in Minnesota to have a supply of opiate antagonists on campus, so they can be used during overdose emergencies. The bill directs the main higher education systems to ensure access to nasal opiate antagonists and provides for training resources and a possible standard plan for storage and administration.

Main provisions

  • Public postsecondary institutions must maintain a supply of opiate antagonists (as defined in state law) on system campuses.
  • At least two doses of a nasal opiate antagonist (e.g., naloxone) must be available on site at each campus residential building.
  • The commissioner of health must identify resources to help campuses implement an opiate antagonist emergency response, including at least one training video, and make these resources available to institutions.
  • The Board of Trustees (for Minnesota State Colleges and Universities) and the Board of Regents (for the University of Minnesota) may adopt a model plan for storage and administration of opiate antagonists on system campuses.

How it changes current law

  • Adds a new statutory requirement to stock opiate antagonists on public postsecondary campuses.
  • Establishes a minimum supply (two nasal doses) specifically in residential buildings.
  • Creates an obligation for the health department to provide training resources and for higher education systems to consider a standardized storage and administration plan.
  • References amending and adding to Minnesota Statutes, linking to existing provisions on opiate antagonists and to new statutory provisions in chapter 135A.

Implementation and responsibilities

  • The Minnesota State Colleges and Universities system and the University of Minnesota are responsible for ensuring the required supply is on each campus, including residential buildings.
  • Campuses may use a model plan for how to store and administer opiate antagonists.
  • The state health department provides training resources to assist campuses in implementing the response.

Resources and training

  • The commissioner of health will identify and provide resources, including at least one training video, to support an opiate antagonist emergency response on campuses.
  • Institutions will use these resources to train staff and students as part of their overdose response readiness.

Potential scope and impact

  • Focuses on overdose prevention and response by integrating access to reversal medication into campus operations.
  • May involve costs related to purchasing nasal naloxone doses, storage requirements, and staff training.
  • Encourages a standardized approach across major public higher education systems.

Relevant Terms opiate antagonist; nasal opiate antagonist; naloxone; overdose reversal; emergency response; campus; public postsecondary institutions; Minnesota State Colleges and Universities (system); University of Minnesota; residential building; two doses; storage; administration; model plan; training video; commissioner of health; Minnesota Statutes 2024 section 151.37 subdivision 12; Minnesota Statutes chapter 135A; section 604A.04 subdivision 1

Bill text versions

Showing the most recent version. There are  6  total versions. You must be logged in  to view additional bill text versions.

Past committee meetings

You must be logged in  to view 2  past legislative committee meetings.

Actions

DateChamberWhereTypeNameCommittee Name
January 16, 2025SenateActionIntroduction and first reading
January 16, 2025SenateActionReferred toHigher Education
January 21, 2025SenateActionAuthor added
February 24, 2025SenateActionComm report: To pass as amended and re-refer toHealth and Human Services
March 06, 2025SenateActionComm report: To pass and re-referred toHigher Education
Showing the 5  most recent stages. This bill has 7  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…